Prognostic significance of angiogenesis in gastrointestinal stromal tumor

被引:51
作者
Imamura, Masakazu
Yamamoto, Hidetaka
Nakamura, Norimoto
Oda, Yoshinao
Yao, Takashi
Kakeji, Yoshihiro
Baba, Hideo
Maehara, Yoshihiko
Tsuneyoshi, Masazumi
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Pathol Anat, Higashi Ku, Fukuoka 8128582, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, Fukuoka, Japan
[3] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto, Japan
基金
日本学术振兴会;
关键词
gastrointestinal stromal tumor; vascular endothelial growth factor; angiogenesis; KIT;
D O I
10.1038/modpathol.3800767
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Angiogenesis is important in the growth and metastasis of various kinds of solid tumors. To investigate the potential role of angiogenesis in gastrointestinal stromal tumor (GIST), an immunohistochemical analysis was performed in 95 cases of GISTs for microvessel density (MVD) and vascular endothelial growth factor (VEGF) expression. MVD was evaluated with immunohistochemical staining for CD31. A high level of MVD was significantly correlated with overexpression of VEGF, tumor location (intestine > stomach), tumor size (>= 5 cm), tumor grade (high > intermediate > low grade) (P= < 0.0001, 0.0422, 0.0006, 0.0359, respectively). Of the 70 GISTs analyzed, KIT exon 11 mutations were detected in 45 cases (64.3%) and KIT exon 9 mutations in two cases (2.9%). No mutations were found in KIT exons 13 and 17, and platelet-derived growth factor receptor-alpha exons 12 and 18. Interestingly, VEGF expression level was significantly higher in the non-KIT exon 11 mutant group than in the KIT exon 11 mutant group (P = 0.0266). In univariate analysis, tumor grade ( high grade), tumor size (>= 5 cm), mitotic count (>= 5/50 high-power fields), Ki-67 labeling index (>= 4.6%), MVD (>= 7.0/0.95 mm(2)) and VEGF expression ( high) were significantly associated with a shorter period of disease-free survival (P = < 0.0001, 0.0199, 0.0055 0.0027, 0.0028 and 0.0302, respectively). In multivariate analysis, tumor grade and MVD were identified as independent worse prognostic factors (P = 0.0007, 0.0152, respectively). In conclusion, our results suggest that the evaluation of MVD and VEGF expression is useful for predicting the aggressive biologic behavior of GIST, and that angiogenesis associated with VEGF may play an important role, at least in part, in the progression of GIST.
引用
收藏
页码:529 / 537
页数:9
相关论文
共 41 条
[1]  
Antonescu CR, 2003, CLIN CANCER RES, V9, P3329
[2]   Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site [J].
Antonescu, CR ;
Viale, A ;
Sarran, L ;
Tschernyavsky, SJ ;
Gonen, M ;
Segal, NH ;
Maki, RG ;
Socci, ND ;
DeMatteo, RP ;
Besmer, P .
CLINICAL CANCER RESEARCH, 2004, 10 (10) :3282-3290
[3]   Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation [J].
Antonescu, CR ;
Besmer, P ;
Guo, TH ;
Arkun, K ;
Hom, G ;
Koryotowski, B ;
Leversha, MA ;
Jeffrey, PD ;
Desantis, D ;
Singer, S ;
Brennan, MF ;
Maki, RG ;
DeMatteo, RP .
CLINICAL CANCER RESEARCH, 2005, 11 (11) :4182-4190
[4]   A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors [J].
Chen, LL ;
Trent, JC ;
Wu, EF ;
Fuller, GN ;
Ramdas, L ;
Zhang, W ;
Raymond, AK ;
Prieto, VG ;
Oyedeji, CO ;
Hunt, KK ;
Pollock, RE ;
Feig, BW ;
Hayes, KJ ;
Choi, H ;
Macapinlac, HA ;
Hittelman, W ;
Velasco, MA ;
Patel, S ;
Burgess, MA ;
Benjamin, RS ;
Frazier, ML .
CANCER RESEARCH, 2004, 64 (17) :5913-5919
[5]   Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression [J].
Choi, WWL ;
Lewis, MM ;
Lawson, D ;
Yin-Goen, QQ ;
Birdsong, GG ;
Cotsonis, GA ;
Cohen, C ;
Young, AN .
MODERN PATHOLOGY, 2005, 18 (01) :143-152
[6]   Biology of gastrointestinal stromal tumors [J].
Corless, CL ;
Fletcher, JA ;
Heinrich, MC .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (18) :3813-3825
[7]   Vascular endothelial growth factor: A therapeutic target for tumors of the Ewing's sarcoma family [J].
Dalal, S ;
Berry, AM ;
Cullinane, CJ ;
Mangham, DC ;
Grimer, R ;
Lewis, IJ ;
Johnston, C ;
Laurence, V ;
Burchill, SA .
CLINICAL CANCER RESEARCH, 2005, 11 (06) :2364-2378
[8]   Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group [J].
Debiec-Rychter, M ;
Dumez, H ;
Judson, I ;
Wasag, B ;
Verweij, J ;
Brown, M ;
Dimitrijevic, S ;
Sciot, R ;
Stul, M ;
Vranck, H ;
Scurr, M ;
Hagemeijer, A ;
Van Glabbeke, M ;
van Oosterom, AT .
EUROPEAN JOURNAL OF CANCER, 2004, 40 (05) :689-695
[9]  
DEMETRI G, 2004, P AN M AM SOC CLIN, V22, P3001
[10]   The biology of vascular endothelial growth factor [J].
Ferrara, N ;
DavisSmyth, T .
ENDOCRINE REVIEWS, 1997, 18 (01) :4-25